397 related articles for article (PubMed ID: 29484429)
21. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data.
Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G
Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
[TBL] [Abstract][Full Text] [Related]
24. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
[TBL] [Abstract][Full Text] [Related]
26. CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression.
Wang H; Chen W; Jin M; Hou L; Chen X; Zhang R; Zhang J; Zhu J
Mol Cancer; 2018 Nov; 17(1):165. PubMed ID: 30470261
[TBL] [Abstract][Full Text] [Related]
27. miR-23b-3p Modulating Cytoprotective Autophagy and Glutamine Addiction in Sorafenib Resistant HepG2, a Hepatocellular Carcinoma Cell Line.
Kaur R; Kanthaje S; Taneja S; Dhiman RK; Chakraborti A
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011286
[TBL] [Abstract][Full Text] [Related]
28. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma.
Wang W; Zhao LJ; Tan YX; Ren H; Qi ZT
World J Gastroenterol; 2012 Oct; 18(38):5442-53. PubMed ID: 23082062
[TBL] [Abstract][Full Text] [Related]
29. High miR-139-3p expression predicts a better prognosis for hepatocellular carcinoma: a pooled analysis.
Zhu Y; Zhou C; He Q
J Int Med Res; 2019 Jan; 47(1):383-390. PubMed ID: 30394818
[TBL] [Abstract][Full Text] [Related]
30. lncRNA-SNHG15 accelerates the development of hepatocellular carcinoma by targeting miR-490-3p/ histone deacetylase 2 axis.
Dai W; Dai JL; Tang MH; Ye MS; Fang S
World J Gastroenterol; 2019 Oct; 25(38):5789-5799. PubMed ID: 31636472
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
[TBL] [Abstract][Full Text] [Related]
32. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
[TBL] [Abstract][Full Text] [Related]
33. miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.
Wang Y; Yang Z; Wang L; Sun L; Liu Z; Li Q; Yao B; Chen T; Wang C; Yang W; Liu Q; Han S
Biomed Pharmacother; 2019 Jan; 109():991-999. PubMed ID: 30551553
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
35. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C-associated hepatocellular carcinoma.
ALrefai AA; Rizk SK; Khamis AK; Kasemy ZA; Habieb MSE
Lab Med; 2024 May; 55(3):310-319. PubMed ID: 37695165
[TBL] [Abstract][Full Text] [Related]
36. miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression.
Fu Y; Sun LQ; Huang Y; Quan J; Hu X; Tang D; Kang R; Li N; Fan XG
Curr Mol Med; 2018; 18(3):135-141. PubMed ID: 30198432
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of microRNA-125b-2-3p is a risk factor for a poor prognosis in hepatocellular carcinoma.
Huang HQ; Chen G; Xiong DD; Lai ZF; Liu LM; Fang YY; Shen JH; Gan XY; Liao LF; Dang YW
Bioengineered; 2021 Dec; 12(1):1627-1641. PubMed ID: 33949293
[TBL] [Abstract][Full Text] [Related]
38. miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
Leong KW; Cheng CW; Wong CM; Ng IO; Kwong YL; Tse E
Oncotarget; 2017 Feb; 8(7):11343-11355. PubMed ID: 28076852
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma.
Soliman MH; Ragheb MA; Elzayat EM; Mohamed MS; El-Ekiaby N; Abdelaziz AI; Abdel-Wahab AA
Anticancer Agents Med Chem; 2021; 21(2):246-253. PubMed ID: 32416702
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA profile in HBV-induced infection and hepatocellular carcinoma.
Wang G; Dong F; Xu Z; Sharma S; Hu X; Chen D; Zhang L; Zhang J; Dong Q
BMC Cancer; 2017 Dec; 17(1):805. PubMed ID: 29191172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
